What is Raysearch (RAYb)?
RaySearch Laboratories AB is a Swedish company specializing in the development of advanced software solutions for radiation therapy and oncology. Founded in 2000, the company focuses on improving cancer treatment through innovative technology that enhances the precision and effectiveness of radiotherapy. RaySearch's products include treatment planning systems and oncology information systems designed to support medical professionals in delivering personalized care. The company collaborates with various medical device manufacturers and healthcare providers worldwide to integrate its software with different radiotherapy equipment. RaySearch's solutions aim to optimize treatment plans, improve patient outcomes, and streamline clinical workflows. The company operates in a highly specialized segment of the healthcare industry, contributing to advancements in cancer treatment methodologies. Its software is used in numerous countries, reflecting a global presence in the field of medical technology. RaySearch continues to invest in research and development to maintain its position in the evolving landscape of oncology software.
Raysearch Stock Price Today: Live Overview
The price today is shaped by current session trading, with Raysearch priced at kr190.2. It has fluctuated between kr186.4 and kr192.6, showing a daily change percentage of 0%.
FAQ: Raysearch (RAYb)
What is the current price of RAYb stock?
The last traded price is kr190.2.
Does RAYb pay dividends?
Raysearch pays dividends via cash distributions (if applicable).
Does RAYb have a formal corporate presence or regional headquarters in the UAE?
Raysearch operates via partners in the UAE and does not have an official regional office or subsidiary.
What is RAYb best known for?
Raysearch is most famous for its advanced software solutions for radiation therapy.
What assets are typically shown together with RAYb?
Commonly shown alongside RAYb: Global X Artificial Intelligence & Technology ETF, Outset Medical, Inc., Camtek Ltd/Israel
Latest shares articles



